1. Home
  2. INTS vs ZDAI Comparison

INTS vs ZDAI Comparison

Compare INTS & ZDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$4.10

Market Cap

13.7M

Sector

Health Care

ML Signal

HOLD

ZDAI

Primega Group Holdings Limited Ordinary Shares

HOLD

Current Price

$1.66

Market Cap

13.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTS
ZDAI
Founded
2012
2022
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
General Bldg Contractors - Nonresidential Bldgs
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
13.6M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
INTS
ZDAI
Price
$4.10
$1.66
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$38.00
N/A
AVG Volume (30 Days)
30.3K
47.1K
Earning Date
05-07-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.20
52 Week High
$8.06
$11.48

Technical Indicators

Market Signals
Indicator
INTS
ZDAI
Relative Strength Index (RSI) 41.78 40.32
Support Level $3.95 $1.59
Resistance Level $5.09 $2.04
Average True Range (ATR) 0.32 0.12
MACD -0.05 0.00
Stochastic Oscillator 8.94 32.08

Price Performance

Historical Comparison
INTS
ZDAI

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

About ZDAI Primega Group Holdings Limited Ordinary Shares

DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.

Share on Social Networks: